How has Rapid Micro Biosystems's other commercial liabilities changed year-over-year?

Rapid Micro Biosystems's other commercial liabilities increased by 29.0% year-over-year, from $5.03M to $6.5M.

What is the long-term trend for Rapid Micro Biosystems's other commercial liabilities?

Over 5 years (2020 to 2025), Rapid Micro Biosystems's other commercial liabilities has grown at a 4.6% compound annual growth rate (CAGR), from $6.65M to $8.32M.

Rapid Micro Biosystems RPID Other Commercial Liabilities

Other Commercial Liabilities at other companies

Charles River LaboratoriesCRL

——

Pacific Biosciences of CaliforniaPACB

——

West Pharmaceutical ServicesWST

——

Lifecore Biomedical, Inc.LFCR

——

Fulgent Genetics, Inc.FLGT

——

Biodesix, Inc.BDSX

——

Other financials

Income statement

See full

Revenue$8.0M+11.1%

Gross profit$371.0K-8.2%

Operating income-$13.9M-18.8%

Net income-$14.3M-26.7%

EPS (diluted)-$0.31-19.2%

Balance sheet

See full

Cash & equivalents$14.1M-26.8%

Total debt$23.8M+301%

Total equity$20.4M-68.9%

Total assets$62.4M-27.0%

Cash flow

See full

Operating cash flow-$15.1M-66.1%

CapEx$394.0K+23.5%

Free cash flow-$15.5M-64.7%

Valuation

See full

Market cap$86.19M-43.8%

Enterprise value$95.86M-31.7%

P/S2.5×-2.6×

Profitability

See full

Operating margin-144.2%-12.7pp

Net margin-145.8%-5.0pp

FCF margin-110.5%-14.9pp

Returns & leverage

See full

Return on equity-116.7%-620pp

Debt / equity1.2×+1.1×

Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapid Micro Biosystems's other commercial liabilities?: Rapid Micro Biosystems (RPID) reported other commercial liabilities of $6.5M in Q1 2026.
How has Rapid Micro Biosystems's other commercial liabilities changed year-over-year?: Rapid Micro Biosystems's other commercial liabilities increased by 29.0% year-over-year, from $5.03M to $6.5M.
What is the long-term trend for Rapid Micro Biosystems's other commercial liabilities?: Over 5 years (2020 to 2025), Rapid Micro Biosystems's other commercial liabilities has grown at a 4.6% compound annual growth rate (CAGR), from $6.65M to $8.32M.